Health
Results: 5317-5328 of 5633

Data Presented at UEG Week 2023 Further Support the Potential of Celltrion’s Investigational Subcutaneous Infliximab CT-P13 SC in the Treatment of Inflammatory Bowel Disease

Tiziana Life Sciences Announces Positive Six-Month Clinical Results in Multiple Sclerosis Patients Treated with Intranasal Foralumab

NuCana Presents Promising Data on NUC-7738 at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2023

Successful Launch of JVM's Next-Generation Automated Drug Dispensing System via High-End Robot Arm 'MENITH' in the European Market

Elsevier introduces geographical pricing pilot to support authors in low- and middle-income countries with equitable open access publishing options

New data from LEQEMBI® (lecanemab-irmb) phase 3 Clarity AD study and subcutaneous formulation to be presented at CTAD
